Literature DB >> 15271997

The S box of major histocompatibility complex class II promoters is a key determinant for recruitment of the transcriptional co-activator CIITA.

Annick Muhlethaler-Mottet1, Michal Krawczyk, Krzysztof Masternak, Charalambos Spilianakis, Androniki Kretsovali, Joseph Papamatheakis, Walter Reith.   

Abstract

Tightly regulated expression of major histocompatibility complex (MHC) class II genes is critical for the immune system. A conserved regulatory module consisting of four cis-acting elements, the W, X, X2 and Y boxes, controls transcription of MHC class II genes. The X, X2, and Y boxes are bound, respectively, by RFX, CREB, and NF-Y to form a MHC class II-specific enhanceosome complex. The latter constitutes a landing pad for recruitment of the transcriptional co-activator CIITA. In contrast to the well defined roles of the X, X2, and Y boxes, the role of the W region has remained controversial. In vitro binding studies have suggested that it might contain a second RFX-binding site. We demonstrate here by means of promoter pull-down assays that the most conserved subsequence within the W region, called the S box, is a critical determinant for tethering of CIITA to the enhanceosome complex. Binding of CIITA to the enhanceosome requires both integrity of the S box and a remarkably stringent spacing between the S and X boxes. Even a 1-2-base pair change in the native S-X distance is detrimental for CIITA recruitment and promoter function. In contrast to current models, binding of RFX to a putative duplicated binding site in the W box is thus not required for either CIITA recruitment or promoter activity. This paves the way for the identification of novel factors mediating the contribution of the S box to the activation of MHC class II promoters. Copyright 2004 American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15271997     DOI: 10.1074/jbc.M406585200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  14 in total

1.  New functions of the major histocompatibility complex class II-specific transcription factor RFXANK revealed by a high-resolution mutagenesis study.

Authors:  Michal Krawczyk; Krzysztof Masternak; Madeleine Zufferey; Emmanuèle Barras; Walter Reith
Journal:  Mol Cell Biol       Date:  2005-10       Impact factor: 4.272

Review 2.  Regulation of major histocompatibility complex class II genes.

Authors:  Nancy M Choi; Parimal Majumder; Jeremy M Boss
Journal:  Curr Opin Immunol       Date:  2010-10-21       Impact factor: 7.486

3.  Suboptimization of developmental enhancers.

Authors:  Emma K Farley; Katrina M Olson; Wei Zhang; Alexander J Brandt; Daniel S Rokhsar; Michael S Levine
Journal:  Science       Date:  2015-10-16       Impact factor: 47.728

4.  ZXDC, a novel zinc finger protein that binds CIITA and activates MHC gene transcription.

Authors:  Wafa Al-Kandari; Srikarthika Jambunathan; Vandana Navalgund; Rupa Koneni; Margot Freer; Neeta Parimi; Rajini Mudhasani; Joseph D Fontes
Journal:  Mol Immunol       Date:  2006-04-04       Impact factor: 4.407

5.  NLRC5 cooperates with the RFX transcription factor complex to induce MHC class I gene expression.

Authors:  Torsten B Meissner; Yuen-Joyce Liu; Kyoung-Hee Lee; Amy Li; Amlan Biswas; Marja C J A van Eggermond; Peter J van den Elsen; Koichi S Kobayashi
Journal:  J Immunol       Date:  2012-04-06       Impact factor: 5.422

Review 6.  Structural aspects of the MHC expression control system.

Authors:  Grady Nash; Bhaskar Paidimuddala; Liman Zhang
Journal:  Biophys Chem       Date:  2022-02-15       Impact factor: 2.352

Review 7.  Regulation of major histocompatibility complex class II gene expression, genetic variation and disease.

Authors:  L Handunnetthi; S V Ramagopalan; G C Ebers; J C Knight
Journal:  Genes Immun       Date:  2009-11-05       Impact factor: 2.676

Review 8.  NLRC5: a key regulator of MHC class I-dependent immune responses.

Authors:  Koichi S Kobayashi; Peter J van den Elsen
Journal:  Nat Rev Immunol       Date:  2012-12       Impact factor: 53.106

9.  Revisiting the specificity of the MHC class II transactivator CIITA in classical murine dendritic cells in vivo.

Authors:  David A Anderson; Gary E Grajales-Reyes; Ansuman T Satpathy; Carlos E Vasquez Hueichucura; Theresa L Murphy; Kenneth M Murphy
Journal:  Eur J Immunol       Date:  2017-07-14       Impact factor: 5.532

10.  Dysregulated recruitment of the histone methyltransferase EZH2 to the class II transactivator (CIITA) promoter IV in breast cancer cells.

Authors:  Agnieszka D Truax; Meghna Thakkar; Susanna F Greer
Journal:  PLoS One       Date:  2012-04-26       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.